Medical device recalls are essential to patient safety, addressing critical issues in devices that may pose health risks. Here are some of the latest recalls reported to the FDA: Airlife and Vyaire ...

On June 30, 2025, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services posted Advisory Opinion 25-05 (AO 25-05) to its website. AO 25-05 is a favorable opinion ...

The FDA has issued its much-anticipated final guidance on cybersecurity risk management in medical devices, effective June ...

ACRO Biomedical, a pioneering biotechnology company based in Taiwan, is proud to announce its participation in Medicall Chennai 2025, where it will unveil the ABCcolla ® Ophthalmic Matrix—a newly ...

Generative AI chatbot for doctors called 'Prof. Valmed' earns E.U. approval. In the U.S., FDA is yet to issue guidelines on ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

Eyebright Medical Technology (Beijing) Ltd (" Eyebright Medical "; SH Stock Code: 688050.SH) is a National High-tech Enterprise and state-level technologically advanced 'little giant' enterprises ...

Developing Class III medical devices, those that are life-sustaining, life-supporting, or implanted, presents some of the major challenges in the healthcare industry.

--The World's First Precisely Regulated Injectable CaHA Filler, Accelerating Compliance in the Medical Aesthetics Industry in China. SHANGHAI, March 21, 2025 /PRNewswire/ -- Shanghai Moyom ...

Moving forward, BCC Research projects that the global medical device industry will increase from US$810.4 billion in 2024 to US$1.3 trillion by 2029, expanding at a compound annual growth rate of ...